Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rbv 2011'

Rbv 2011 published presentations and documents on DocSlides.

MK3 MK3 + RBV

MK3 MK3 + RBV

  • min-jolicoeur
  • 10 Slides

Randomisation. Open-label. W8. * Liver biopsy or ...

SOF + EBR + GZR + RBV

SOF + EBR + GZR + RBV

  • test
  • 4 Slides

N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...

SOF + RBV

SOF + RBV

  • debby-jeon
  • 7 Slides

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

PEG alfa-2a RBV versus

PEG alfa-2a RBV versus

  • alexa-scheidler
  • 0 Slides

. PEG alfa-. 2a . versus. INF RBV . APRICOT S...

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

  • sophia2
  • 9 Slides

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

  • UnicornLove
  • 7 Slides

C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...

Current strategies for the management of treatment naïve a

Current strategies for the management of treatment naïve a

  • min-jolicoeur
  • 60 Slides

Mark S. Sulkowski, MD. Medical Director, Viral He...

Direct Acting Antivirals: What are they? What is their pl

Direct Acting Antivirals: What are they? What is their pl

  • tawny-fly
  • 28 Slides

Mark Sulkowski, MD. Associate Professor of Medici...

Updates in Treatment of Hepatitis C

Updates in Treatment of Hepatitis C

  • myesha-ticknor
  • 0 Slides

Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...

Updates in Treatment of Hepatitis C

Updates in Treatment of Hepatitis C

  • cheryl-pisano
  • 0 Slides

Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...

NS5A and polymerase inhibitors

NS5A and polymerase inhibitors

  • LoveBug
  • 16 Slides

Mark Sulkowski, MD. Professor of Medicine. Johns H...

Reddy KR. Lancet Infect Dis. 2015;15:27-35

Reddy KR. Lancet Infect Dis. 2015;15:27-35

  • natalia-silvester
  • 6 Slides

ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...

Design

Design

  • test
  • 8 Slides

PTV150/r + OBV + . DSV . + RBV. PTV150/r + . DSV...

State of the Art Therapy for HCV

State of the Art Therapy for HCV

  • liane-varnes
  • 56 Slides

Last Updated: February . 21, 2014. Robert G. Gish...

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

  • kittie-lecroy
  • 48 Slides

Mark Sulkowski, MD . Professor of Medicine. Medic...

Out With the Old and In With the New, Again?

Out With the Old and In With the New, Again?

  • test
  • 37 Slides

Out With the Old, In With the New. Current Standa...

Edited by

Edited by

  • celsa-spraggs
  • 137 Slides

Morris Sherman MD . BCh. PhD FRCP(C) . Associate...

HIV and HCV Update for the Pharmacist – June 2014

HIV and HCV Update for the Pharmacist – June 2014

  • marina-yarberry
  • 60 Slides

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...

3 D (Paritaprevir

3 D (Paritaprevir

  • myesha-ticknor
  • 13 Slides

-Ritonavir. -Ombitasvir . + Dasabuvir) . + RBV in...

C-SCAPE

C-SCAPE

  • pasty-toler
  • 14 Slides

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

SIRIUS

SIRIUS

  • tawny-fly
  • 10 Slides

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

TURQUOISE-I

TURQUOISE-I

  • natalia-silvester
  • 5 Slides

OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...

GZR + EBR

GZR + EBR

  • celsa-spraggs
  • 5 Slides

C-WORTHY Study Part C: . grazoprevir. . + . elba...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

  • cheryl-pisano
  • 36 Slides

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

Dore G. J

Dore G. J

  • pasty-toler
  • 10 Slides

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

Randomisation

Randomisation

  • pamella-moone
  • 10 Slides

*. 1:1. Open-label. ≥ 18 years. HCV genotype ...

SOF/VEL

SOF/VEL

  • trish-goza
  • 6 Slides

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

Étude PEARL III : ABT-450/r/267 + ABT-333 ± RBV

Étude PEARL III : ABT-450/r/267 + ABT-333 ± RBV

  • tatiana-dople
  • 4 Slides

dans les génotypes 1b naïfs de traitement . (1)...

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

  • yoshiko-marsland
  • 14 Slides

TURQUOISE-II. Phase 3. . Treatment. Naïve and ...

David Fletcher, MD

David Fletcher, MD

  • tatiana-dople
  • 24 Slides

Department of Medicine. University of Toronto. Co...

C-SCAPE

C-SCAPE

  • tawny-fly
  • 10 Slides

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

TURQUOISE-I

TURQUOISE-I

  • marina-yarberry
  • 11 Slides

OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...

C-WORTHY Study Part

C-WORTHY Study Part

  • karlyn-bohler
  • 12 Slides

D : . grazoprevir. . + . elbasvir. + RBV in ge...

PEG alfa-2a +

PEG alfa-2a +

  • tawny-fly
  • 8 Slides

RBV . versus. . PEG alfa-. 2a . versus. INF + R...

Dore G. J

Dore G. J

  • myesha-ticknor
  • 9 Slides

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

Ombitasvir-

Ombitasvir-

  • kittie-lecroy
  • 9 Slides

Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...

SAPPHIRE-I

SAPPHIRE-I

  • ellena-manuel
  • 8 Slides

Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...

Elbasvir

Elbasvir

  • calandra-battersby
  • 6 Slides

+ . Grazoprevir. +/- Ribavirin in . Treatment-N...

SMV 12W + PEG-IFN + RBV 24-48W **

SMV 12W + PEG-IFN + RBV 24-48W **

  • alexa-scheidler
  • 5 Slides

SMV 24W + PEG-IFN + RBV 24-48W **. Randomisation ...

SOF/VEL + RBV

SOF/VEL + RBV

  • celsa-spraggs
  • 5 Slides

N = 69. >. 18 years. Failure to SOF/VEL . or ...

Copyright © 2024 DocSlides. All Rights Reserved